Clinical Trials on Rheumatologic Diseases

Total 379692 results

Baylor College of Medicine

Completed

Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders

Oncologic Disorders | Hematologic Disorders | Rheumatologic Disorders

United States
Vlad Radulescu

Completed

Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis/Treatment

Cancer | Infertility | Rheumatologic Disorder | Hematologic Disorder

United States
St. Jude Children's Research Hospital

Recruiting

Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products

Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy

United States
Nantes University Hospital

Not yet recruiting

Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation (CY-MET-RIC)

Hematologic Malignancy | Graft Versus Host Disease
Nelson Chao
National Center for Advancing Translational Sciences (NCATS); Mereo BioPharma

Withdrawn

MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Hematologic Malignancy

United States
Universitaire Ziekenhuizen KU Leuven
B. Braun Medical SA; RITA Medical Systems

Completed

Functional Evaluation of Two Types of Totally Implanted Venous Ports

Hematologic Disease

Belgium
University of Colorado, Denver

Not yet recruiting

TCR Alpha/Beta and CD19-deplete Haplo-HSCT

Hematologic Malignancy | Pediatric Patients | Other Hematologic Condition

United States
Epizyme, Inc.

Withdrawn

A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer. (ARIA)

Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy

United States
National Institutes of Health Clinical Center (CC)

Completed

Evaluation of Patients With Blood Disorders

Hematologic Disease

United States
Leuko Labs, Inc.
M.D. Anderson Cancer Center; Center for Advancing Point of Care Technologies...

Recruiting

Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population (PC004)

Hematologic Malignancy

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

Hematologic Malignancy

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic Malignancy

Hematologic Malignancy

China
Massachusetts General Hospital

Recruiting

Evaluation of PET/MRI in Children With Cancer

Hematologic Malignancy

United States
Fondazione EMN Italy Onlus

Completed

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation (TLI)

HEMATOLOGIC MALIGNANCIES

Italy
Center for International Blood and Marrow Transplant...
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704) (BMT CTN 1704)

Hematologic Malignancy

United States
Rigshospitalet, Denmark
Novo Nordisk A/S

Completed

Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care (SIMPly-CARE)

Hematologic Malignancy

Denmark
SecuraBio

Completed

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

Hematologic Malignancy

United States, Italy
Duke University

Active, not recruiting

A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)

Hematologic Malignancy

United States
St. Petersburg State Pavlov Medical University

Completed

Effects of Parenteral Nutrition in HSCT

Hematologic Malignancy

Russian Federation
Abramson Cancer Center of the University of Pennsylvania

Completed

Phase II Maraviroc for GVHD Prevention

Hematologic Malignancy

United States
Nantes University Hospital

Completed

Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens (FB4-PEDIA)

Hematologic Malignancy

France
Seoul National University Hospital
The Korean Society of Blood and Marrow Transplantation

Unknown

Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients

Hematologic Malignancy
Istituto Clinico Humanitas

Terminated

Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow

Hematologic Malignancy

Italy
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Intervention for Fatigue in HCT Recipients

Hematologic Malignancy | Hematologic Cancer

United States
Dana-Farber Cancer Institute

Terminated

Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies

Hematologic Malignancy

United States
University Hospital Tuebingen

Recruiting

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT (CD45RADLIHaplo)

Hematologic Malignancy

Germany
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Molecular-genetic Characterization in Patients Undergoing CAR-T Cell Infusion (CAR_22)

Hematologic Malignancy

Italy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

Hematologic Malignancy

China
Duke University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

Hematologic Malignancy

United States
NYU Langone Health

Active, not recruiting

A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT

Hematologic Malignancy

United States
Memorial Sloan Kettering Cancer Center

Completed

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Hematologic Malignancy

United States
Garcia, Jose M., MD, PhD

Active, not recruiting

Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation

Hematologic Malignancy

United States
Duke University

Completed

Mindfulness and CBT for Sleep

Hematologic Malignancy

United States
Maisonneuve-Rosemont Hospital
Canadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St.... and other collaborators

Completed

Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant

Hematologic Malignancy

Canada
Massachusetts General Hospital

Completed

Non Invasive Optical Imaging of WBC Count

Hematologic Malignancy

United States
Alberta Health services

Unknown

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Hematologic Malignancy

Canada
Cooperative Study Group A for Hematology

Completed

Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells

HEMATOLOGIC MALIGNANCIES

Korea, Republic of
Meir Medical Center

Unknown

Assessment of Ovarian Reserve in Women With Rheumatologic Diseases

Infertility | Ovarian Reserve | Rheumatologic Diseases

Israel
Washington University School of Medicine

Recruiting

Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies

Pediatric Hematologic Malignancies

United States
A.O. Ospedale Papa Giovanni XXIII

Recruiting

Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant (Haplo-CIK)

Relapsed Hematologic Malignancy

Italy
Peking University People's Hospital

Recruiting

ATG Plus Low-dose PT-Cy for GVHD Prevention

Hematologic Malignancy

China
Prolacta Bioscience

Recruiting

Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

Hematologic Malignancy

United States
Dana-Farber Cancer Institute

Recruiting

Home Transfusion for HEME

Hematologic Malignancy

United States
Northside Hospital, Inc.

Recruiting

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Hematologic Malignancy

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation (B-REC)

Hematologic Malignancy
St. Petersburg State Pavlov Medical University

Active, not recruiting

Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

Hematologic Malignancy

Russian Federation
Exact Sciences Corporation

Terminated

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies

Hematologic Malignancy

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Hematologic Malignancy

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

Reiki as a Complementary Therapy: A Pilot Study

Hematologic Malignancy

United States
University of California, San Diego

Terminated

An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme) (I-PREDICT Heme)

Hematologic Cancer

United States

Clinical Trials on Rheumatologic Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations